Capecitabine, is a kind of fluorine pyrimidine carbamate deoxyuridine drug that can transform into 5 - FU in the body and inhibit cell division and disturb the synthesis of RNA and protein. Capecitabines applies to the further treatment of advanced primary or metastatic breast cancer that failed to respond to other chemotherapy regimens including anthracycline antibiotics. Its main usage is treating advanced primary or metastatic breast cancer, rectal cancer, colon cancer and stomach cancer.
Capecitabine is an anti-metabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted into 5-FU in the body, which can inhibit cell division and interfere with RNA and protein synthesis.
It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer that is ineffective in chemotherapy regimens including anthracycline antibiotics. Mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
